Skip to content
GovLens is in free beta — full access while we build. Join the beta →
← 🇩🇪 Bundestag/SCHRIFTLICHE FRAGEdip-317909

Veröffentlichung der Studie "Risikoevaluation COVID-19-Impfstoffe"

Stage otherUpdated 4mo ago

This procedure concerns the publication of a study evaluating the risks associated with COVID-19 vaccines. It aims to provide transparent information to the public and policymakers regarding vaccine safety. The study's findings will be relevant to public health authorities, healthcare professionals, and citizens making informed decisions about vaccination.